DAXILUME Trademark

Trademark Overview


On Tuesday, June 2, 2015, a trademark application was filed for DAXILUME with the United States Patent and Trademark Office. The USPTO has given the DAXILUME trademark a serial number of 86648882. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 9, 2018. This trademark is owned by Pfizer Inc.. The DAXILUME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
daxilume

General Information


Serial Number86648882
Word MarkDAXILUME
Filing DateTuesday, June 2, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 9, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Translation of Words in MarkThe wording "DAXILUME" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 8, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, April 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 9, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2017EXTENSION 3 GRANTED
Thursday, August 10, 2017EXTENSION 3 FILED
Thursday, August 10, 2017TEAS EXTENSION RECEIVED
Wednesday, February 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2017EXTENSION 2 GRANTED
Monday, February 6, 2017EXTENSION 2 FILED
Monday, February 6, 2017TEAS EXTENSION RECEIVED
Friday, August 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 17, 2016EXTENSION 1 GRANTED
Wednesday, August 17, 2016EXTENSION 1 FILED
Wednesday, August 17, 2016TEAS EXTENSION RECEIVED
Tuesday, March 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2016PUBLISHED FOR OPPOSITION
Thursday, December 24, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 3, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 3, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, December 3, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 3, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, December 3, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 2, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 2, 2015NON-FINAL ACTION WRITTEN
Friday, August 28, 2015ASSIGNED TO EXAMINER
Monday, June 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 5, 2015NEW APPLICATION ENTERED IN TRAM